Provided by Tiger Trade Technology Pte. Ltd.

Compugen

2.62
-0.0350-1.32%
Post-market: 2.620.0050+0.19%19:30 EDT
Volume:447.16K
Turnover:1.20M
Market Cap:247.26M
PE:7.00
High:2.77
Open:2.64
Low:2.61
Close:2.65
52wk High:3.24
52wk Low:1.30
Shares:94.55M
Float Shares:92.46M
Volume Ratio:1.32
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3733
EPS(LYR):0.3783
ROE:50.64%
ROA:15.46%
PB:2.79
PE(LYR):6.91

Loading ...

H.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)

TIPRANKS
·
Aug 04

Compugen Announces Annual Shareholder Meeting

Reuters
·
Aug 03

Online Deals Firm Giftify's Q2 Net Loss Narrows After Higher Agent Transactions

Reuters
·
Aug 03

Compugen Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 03

QHSLab's Q2 Revenue Rises on ISP Growth

Reuters
·
Aug 03

Compugen Publishes Corporate Presentation on AI-Driven Immuno-Oncology Antibody Pipeline

Reuters
·
Aug 03

Compugen Q2 FY26 Net Loss Narrows to USD 7 Million; Revenue More than Doubled to USD 2.6 Million

Reuters
·
Aug 03

Compugen Q2 EPS $(0.07), Inline, Sales $2.602M Beat $1.606M Estimate

Benzinga Earnings
·
Aug 03

Press Release: Compugen Reports Second Quarter 2026 Results

Dow Jones
·
Aug 03

Compugen Ltd Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Compugen (CGEN), Telix Pharmaceuticals (OtherTLPPF) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
Jul 22

Compugen to Release Q2 2026 Results, Host Conference Call

Reuters
·
Jul 20

Compugen SVP Business Development Zurit Levine Disposes of 1,875 Common Shares Worth $4,687.5

Reuters
·
Jul 14

Compugen management to meet virtually with Lake Street

TIPRANKS
·
Jul 11

Compugen presents MAIA-ovarian platform trial poster for COM701 maintenance in relapsed platinum-sensitive ovarian cancer at ESMO congress

Reuters
·
Jun 18

H.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)

TIPRANKS
·
Jun 04

Compugen Is Maintained at Outperform by Leerink Partners

Dow Jones
·
May 21

Compugen price target lowered to $5 from $13 at Leerink

TIPRANKS
·
May 21

Compugen Earnings Call Highlights Trials, Cash Runway

TIPRANKS
·
May 20